Risk of cancer in patients with inflammatory bowel diseases: A nationwide population-based cohort study with 30 years of follow-up evaluation

Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study

Katsanos, K.H.
Tatsioni, A.
Pedersen, N.
Shuhaibar, M.
Ramirez, V.H.
Politi, P.
Rombrechts, E.
Pierik, M.
Clofent, J.
Beltrami, M.
Bodini, P.
Freitas, J.
Mouzas, I.
Fornaciari, G.
Moum, B.
Lakatos, P.L.
Vermeire, S.
Langholz, E.
Odes, S.
Morain, C.O.
Stockbrugger, R.
Munkholm, P.
Tsianos, E.V.

October 2011

AIM OF THE STUDY: To determine the occurrence of intestinal and extraintestinal cancers in the 1993-...

Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study

Katsanos, K.H.
Tatsioni, A.
Pedersen, N.
Shuhaibar, M.
Ramirez, V.H.
Politi, P.
Rombrechts, E.
Pierik, M.
Clofent, J.
Beltrami, M.
Bodini, P.
Freitas, J.
Mouzas, I.
Fornaciari, G.
Moum, B.
Lakatos, P.L.
Vermeire, S.
Langholz, E.
Odes, S.
Morain, C.O.
Stockbrugger, R.
Munkholm, P.
Tsianos, E.V.

October 2011

AIM OF THE STUDY: To determine the occurrence of intestinal and extraintestinal cancers in the 1993-...

Declining risk of colorectal cancer in inflammatory bowel disease : an updated meta-analysis of population-based cohort studies

M.W. Lutgens
M.G. van Oijen
G.J. van der Heijden
F.P. Vleggaar
P.D. Siersema
B. Oldenburg
S. Ardizzone

January 2013

Recently reported risks of colorectal cancer (CRC) in inflammatory bowel disease (IBD) have been low...

Risk of cancer in patients with inflammatory bowel diseases: A nationwide population-based cohort study with 30 years of follow-up evaluation

Kappelman, Michael D.
Farkas, Dora K.
Long, Millie D.
Erichsen, Rune
Sandler, Robert S.
Sørensen, Henrik T.
Baron, John A.

January 2014

Data regarding the risk of gastrointestinal and extra-intestinal cancers in Crohn’s disease (CD) and...

Cancer risk in inflammatory bowel disease according to patient phenotype and treatment:a Danish population-based cohort study

Jess, Tine
Horváth-Puhó, Erzsébet
Fallingborg, Jan
Rasmussen, Henrik H
Jacobsen, Bent A

December 2013

OBJECTIVES: Population-based studies of site-specific cancer risk in patients with inflammatory bowe...

Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort

van den Heuvel, Tim R. A.
Wintjens, Dion S. J.
Jeuring, Steven F. G.
Wassink, Maartje H. H.
Romberg-Camps, Marielle J. L.
Oostenbrug, Liekele E.
Sanduleanu, Silvia
Hameeteman, Wim H.
Zeegers, Maurice P.
Masclee, Ad A.
Jonkers, Daisy M.
Pierik, Marieke

September 2016

The management of inflammatory bowel disease (IBD) has changed since the mid-1990s (e.g., use of thi...

Malignancies in Patients with Inflammatory Bowel Disease: Results from 20 Years of Follow-up in the IBSEN Study

Hovde, Øistein
Høivik, Marte Lie
Henriksen, Magne
Solberg, Inger Camilla
Småstuen, Milada Cvancarova
Moum, Bjørn A.

January 2016

Background and Aims: Whether patients with inflammatory bowel diseases [IBDs] have increased risk of...

Cancer Risk in Inflammatory Bowel Disease

Anders M Ekbom

January 1995

There is an increased risk of cancer in both ulcerative colitis and Crohn's disease. In 3121 patient...

Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort

van den Heuvel, Tim R. A.
Wintjens, Dion S. J.
Jeuring, Steven F. G.
Wassink, Maartje H. H.
Romberg-Camps, Marielle J. L.
Oostenbrug, Liekele E.
Sanduleanu, Silvia
Hameeteman, Wim H.
Zeegers, Maurice P.
Masclee, Ad A.
Jonkers, Daisy M.
Pierik, Marieke

September 2016

The management of inflammatory bowel disease (IBD) has changed since the mid-1990s (e.g., use of thi...

Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort

van den Heuvel, Tim R. A.
Wintjens, Dion S. J.
Jeuring, Steven F. G.
Wassink, Maartje H. H.
Romberg-Camps, Marielle J. L.
Oostenbrug, Liekele E.
Sanduleanu, Silvia
Hameeteman, Wim H.
Zeegers, Maurice P.
Masclee, Ad A.
Jonkers, Daisy M.
Pierik, Marieke

September 2016

The management of inflammatory bowel disease (IBD) has changed since the mid-1990s (e.g., use of thi...

Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study

Katsanos, K.H.
Tatsioni, A.
Pedersen, N.
Shuhaibar, M.
Ramirez, V.H.
Politi, P.
Rombrechts, E.
Pierik, M.
Clofent, J.
Beltrami, M.
Bodini, P.
Freitas, J.
Mouzas, I.
Fornaciari, G.
Moum, B.
Lakatos, P.L.
Vermeire, S.
Langholz, E.
Odes, S.
Morain, C.O.
Stockbrugger, R.
Munkholm, P.
Tsianos, E.V.

October 2011

AIM OF THE STUDY: To determine the occurrence of intestinal and extraintestinal cancers in the 1993-...

Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study

Katsanos, K.H.
Tatsioni, A.
Pedersen, N.
Shuhaibar, M.
Ramirez, V.H.
Politi, P.
Rombrechts, E.
Pierik, M.
Clofent, J.
Beltrami, M.
Bodini, P.
Freitas, J.
Mouzas, I.
Fornaciari, G.
Moum, B.
Lakatos, P.L.
Vermeire, S.
Langholz, E.
Odes, S.
Morain, C.O.
Stockbrugger, R.
Munkholm, P.
Tsianos, E.V.

October 2011

AIM OF THE STUDY: To determine the occurrence of intestinal and extraintestinal cancers in the 1993-...

Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study

Katsanos, K.H.
Tatsioni, A.
Pedersen, N.
Shuhaibar, M.
Ramirez, V.H.
Politi, P.
Rombrechts, E.
Pierik, M.
Clofent, J.
Beltrami, M.
Bodini, P.
Freitas, J.
Mouzas, I.
Fornaciari, G.
Moum, B.
Lakatos, P.L.
Vermeire, S.
Langholz, E.
Odes, S.
Morain, C.O.
Stockbrugger, R.
Munkholm, P.
Tsianos, E.V.

October 2011

AIM OF THE STUDY: To determine the occurrence of intestinal and extraintestinal cancers in the 1993-...

Cancer risk in inflammatory bowel disease : a 6-year prospective multicenter nested case-control IG-IBD study

L. Biancone
A. Armuzzi
M.L. Scribano
F. Castiglione
R. D&apos
A. Orlando
C. Papi
M. Daperno
M. Vecchi
G. Riegler
W. Fries
P. Alvisi
G. Meucci
F. Mocciaro
F. Rogai
S. Festa
L. Guidi
A. Testa
L. Spina
S. Renna
A. Viola
M. Patturelli
R. Di Mitri
I. Frankovic
E. Calabrese
C. Petruzziello
E. De Cristofaro
G. Sena
A. Ruffa
B. Neri
A. Rossi

March 2020

BACKGROUND: In a 6-year, multicenter, prospective nested case-control study, we aimed to evaluate ri...

Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study

Katsanos, K.H.
Tatsioni, A.
Pedersen, N.
Shuhaibar, M.
Ramirez, V.H.
Politi, P.
Rombrechts, E.
Pierik, M.
Clofent, J.
Beltrami, M.
Bodini, P.
Freitas, J.
Mouzas, I.
Fornaciari, G.
Moum, B.
Lakatos, P.L.
Vermeire, S.
Langholz, E.
Odes, S.
Morain, C.O.
Stockbrugger, R.
Munkholm, P.
Tsianos, E.V.

October 2011

AIM OF THE STUDY: To determine the occurrence of intestinal and extraintestinal cancers in the 1993-...

Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study

Katsanos, K.H.
Tatsioni, A.
Pedersen, N.
Shuhaibar, M.
Ramirez, V.H.
Politi, P.
Rombrechts, E.
Pierik, M.
Clofent, J.
Beltrami, M.
Bodini, P.
Freitas, J.
Mouzas, I.
Fornaciari, G.
Moum, B.
Lakatos, P.L.
Vermeire, S.
Langholz, E.
Odes, S.
Morain, C.O.
Stockbrugger, R.
Munkholm, P.
Tsianos, E.V.

October 2011

AIM OF THE STUDY: To determine the occurrence of intestinal and extraintestinal cancers in the 1993-...

Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study

Katsanos, K.H.
Tatsioni, A.
Pedersen, N.
Shuhaibar, M.
Ramirez, V.H.
Politi, P.
Rombrechts, E.
Pierik, M.
Clofent, J.
Beltrami, M.
Bodini, P.
Freitas, J.
Mouzas, I.
Fornaciari, G.
Moum, B.
Lakatos, P.L.
Vermeire, S.
Langholz, E.
Odes, S.
Morain, C.O.
Stockbrugger, R.
Munkholm, P.
Tsianos, E.V.

October 2011

AIM OF THE STUDY: To determine the occurrence of intestinal and extraintestinal cancers in the 1993-...

Declining risk of colorectal cancer in inflammatory bowel disease : an updated meta-analysis of population-based cohort studies

M.W. Lutgens
M.G. van Oijen
G.J. van der Heijden
F.P. Vleggaar
P.D. Siersema
B. Oldenburg
S. Ardizzone

January 2013

Recently reported risks of colorectal cancer (CRC) in inflammatory bowel disease (IBD) have been low...

Risk of cancer in patients with inflammatory bowel diseases: A nationwide population-based cohort study with 30 years of follow-up evaluation

Kappelman, Michael D.
Farkas, Dora K.
Long, Millie D.
Erichsen, Rune
Sandler, Robert S.
Sørensen, Henrik T.
Baron, John A.

January 2014

Data regarding the risk of gastrointestinal and extra-intestinal cancers in Crohn’s disease (CD) and...

Cancer risk in inflammatory bowel disease according to patient phenotype and treatment:a Danish population-based cohort study

Jess, Tine
Horváth-Puhó, Erzsébet
Fallingborg, Jan
Rasmussen, Henrik H
Jacobsen, Bent A

December 2013

OBJECTIVES: Population-based studies of site-specific cancer risk in patients with inflammatory bowe...

Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort

van den Heuvel, Tim R. A.
Wintjens, Dion S. J.
Jeuring, Steven F. G.
Wassink, Maartje H. H.
Romberg-Camps, Marielle J. L.
Oostenbrug, Liekele E.
Sanduleanu, Silvia
Hameeteman, Wim H.
Zeegers, Maurice P.
Masclee, Ad A.
Jonkers, Daisy M.
Pierik, Marieke

September 2016

The management of inflammatory bowel disease (IBD) has changed since the mid-1990s (e.g., use of thi...

Malignancies in Patients with Inflammatory Bowel Disease: Results from 20 Years of Follow-up in the IBSEN Study

Hovde, Øistein
Høivik, Marte Lie
Henriksen, Magne
Solberg, Inger Camilla
Småstuen, Milada Cvancarova
Moum, Bjørn A.

January 2016

Background and Aims: Whether patients with inflammatory bowel diseases [IBDs] have increased risk of...

Cancer Risk in Inflammatory Bowel Disease

Anders M Ekbom

January 1995

There is an increased risk of cancer in both ulcerative colitis and Crohn's disease. In 3121 patient...

Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort

van den Heuvel, Tim R. A.
Wintjens, Dion S. J.
Jeuring, Steven F. G.
Wassink, Maartje H. H.
Romberg-Camps, Marielle J. L.
Oostenbrug, Liekele E.
Sanduleanu, Silvia
Hameeteman, Wim H.
Zeegers, Maurice P.
Masclee, Ad A.
Jonkers, Daisy M.
Pierik, Marieke

September 2016

The management of inflammatory bowel disease (IBD) has changed since the mid-1990s (e.g., use of thi...

Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort

van den Heuvel, Tim R. A.
Wintjens, Dion S. J.
Jeuring, Steven F. G.
Wassink, Maartje H. H.
Romberg-Camps, Marielle J. L.
Oostenbrug, Liekele E.
Sanduleanu, Silvia
Hameeteman, Wim H.
Zeegers, Maurice P.
Masclee, Ad A.
Jonkers, Daisy M.
Pierik, Marieke

September 2016

The management of inflammatory bowel disease (IBD) has changed since the mid-1990s (e.g., use of thi...

Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study

Katsanos, K.H.
Tatsioni, A.
Pedersen, N.
Shuhaibar, M.
Ramirez, V.H.
Politi, P.
Rombrechts, E.
Pierik, M.
Clofent, J.
Beltrami, M.
Bodini, P.
Freitas, J.
Mouzas, I.
Fornaciari, G.
Moum, B.
Lakatos, P.L.
Vermeire, S.
Langholz, E.
Odes, S.
Morain, C.O.
Stockbrugger, R.
Munkholm, P.
Tsianos, E.V.

October 2011

AIM OF THE STUDY: To determine the occurrence of intestinal and extraintestinal cancers in the 1993-...

Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study

Katsanos, K.H.
Tatsioni, A.
Pedersen, N.
Shuhaibar, M.
Ramirez, V.H.
Politi, P.
Rombrechts, E.
Pierik, M.
Clofent, J.
Beltrami, M.
Bodini, P.
Freitas, J.
Mouzas, I.
Fornaciari, G.
Moum, B.
Lakatos, P.L.
Vermeire, S.
Langholz, E.
Odes, S.
Morain, C.O.
Stockbrugger, R.
Munkholm, P.
Tsianos, E.V.

October 2011

AIM OF THE STUDY: To determine the occurrence of intestinal and extraintestinal cancers in the 1993-...

Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study

Katsanos, K.H.
Tatsioni, A.
Pedersen, N.
Shuhaibar, M.
Ramirez, V.H.
Politi, P.
Rombrechts, E.
Pierik, M.
Clofent, J.
Beltrami, M.
Bodini, P.
Freitas, J.
Mouzas, I.
Fornaciari, G.
Moum, B.
Lakatos, P.L.
Vermeire, S.
Langholz, E.
Odes, S.
Morain, C.O.
Stockbrugger, R.
Munkholm, P.
Tsianos, E.V.

October 2011

AIM OF THE STUDY: To determine the occurrence of intestinal and extraintestinal cancers in the 1993-...

Cancer risk in inflammatory bowel disease : a 6-year prospective multicenter nested case-control IG-IBD study

L. Biancone
A. Armuzzi
M.L. Scribano
F. Castiglione
R. D&apos
A. Orlando
C. Papi
M. Daperno
M. Vecchi
G. Riegler
W. Fries
P. Alvisi
G. Meucci
F. Mocciaro
F. Rogai
S. Festa
L. Guidi
A. Testa
L. Spina
S. Renna
A. Viola
M. Patturelli
R. Di Mitri
I. Frankovic
E. Calabrese
C. Petruzziello
E. De Cristofaro
G. Sena
A. Ruffa
B. Neri
A. Rossi

March 2020

BACKGROUND: In a 6-year, multicenter, prospective nested case-control study, we aimed to evaluate ri...

Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study

Katsanos, K.H.
Tatsioni, A.
Pedersen, N.
Shuhaibar, M.
Ramirez, V.H.
Politi, P.
Rombrechts, E.
Pierik, M.
Clofent, J.
Beltrami, M.
Bodini, P.
Freitas, J.
Mouzas, I.
Fornaciari, G.
Moum, B.
Lakatos, P.L.
Vermeire, S.
Langholz, E.
Odes, S.
Morain, C.O.
Stockbrugger, R.
Munkholm, P.
Tsianos, E.V.

October 2011

AIM OF THE STUDY: To determine the occurrence of intestinal and extraintestinal cancers in the 1993-...

Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study

Katsanos, K.H.
Tatsioni, A.
Pedersen, N.
Shuhaibar, M.
Ramirez, V.H.
Politi, P.
Rombrechts, E.
Pierik, M.
Clofent, J.
Beltrami, M.
Bodini, P.
Freitas, J.
Mouzas, I.
Fornaciari, G.
Moum, B.
Lakatos, P.L.
Vermeire, S.
Langholz, E.
Odes, S.
Morain, C.O.
Stockbrugger, R.
Munkholm, P.
Tsianos, E.V.

October 2011

AIM OF THE STUDY: To determine the occurrence of intestinal and extraintestinal cancers in the 1993-...

Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study

Katsanos, K.H.
Tatsioni, A.
Pedersen, N.
Shuhaibar, M.
Ramirez, V.H.
Politi, P.
Rombrechts, E.
Pierik, M.
Clofent, J.
Beltrami, M.
Bodini, P.
Freitas, J.
Mouzas, I.
Fornaciari, G.
Moum, B.
Lakatos, P.L.
Vermeire, S.
Langholz, E.
Odes, S.
Morain, C.O.
Stockbrugger, R.
Munkholm, P.
Tsianos, E.V.

October 2011

AIM OF THE STUDY: To determine the occurrence of intestinal and extraintestinal cancers in the 1993-...

Declining risk of colorectal cancer in inflammatory bowel disease : an updated meta-analysis of population-based cohort studies

M.W. Lutgens
M.G. van Oijen
G.J. van der Heijden
F.P. Vleggaar
P.D. Siersema
B. Oldenburg
S. Ardizzone

January 2013

Recently reported risks of colorectal cancer (CRC) in inflammatory bowel disease (IBD) have been low...

Risk of cancer in patients with inflammatory bowel diseases: A nationwide population-based cohort study with 30 years of follow-up evaluation

Abstract

Extracted data

Risk of cancer in patients with inflammatory bowel diseases: A nationwide population-based cohort study with 30 years of follow-up evaluation

Abstract

Extracted data

Related items

Related items